Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
NCT04643366
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DRUG:
Chemotherapy
RADIATION:
Radiation Therapy
Sponsor
Virginia Commonwealth University